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This study aims to explore the potential impairment of Theory of Mind (ToM; i.e., the
ability to represent cognitive and affective mental states to both self and others) and
the clinical, neuropsychological and Quality of Life (QoL) correlates of these cognitive
abnormalities in the early stages of amyotrophic lateral sclerosis (ALS), a multisystem
neurodegenerative disease recently recognized as a part of the same clinical and
pathological spectrum of frontotemporal lobar degeneration. Twenty-two consecutive,
cognitively intact ALS patients, and 15 healthy controls, underwent assessment of
executive, verbal comprehension, visuospatial, behavioral, and QoL measures, as well
as of the ToM abilities by Emotion Attribution Task (EAT), Advanced Test of ToM (ATT),
and Eyes Task (ET). ALS patients obtained significantly lower scores than controls on
EAT and ET. No significant difference was found between the two groups on ATT. As
regard to type of ALS onset, patients with bulbar onset performed worse than those
with spinal onset on ET. Correlation analysis revealed that EAT and ET were positively
correlated with education, memory prose, visuo-spatial performances, and “Mental
Health” scores among QoL items. Our results suggest that not only “cognitive” but
also “affective” subcomponents of ToM may be impaired in the early stages of ALS,
with significant linkage to disease onset and dysfunctions of less executively demanding
conditions, causing potential impact on patients’ “Mental Health.”
Keywords: amyotrophic lateral sclerosis, theory of mind, social cognition, emotion attribution, quality of life
INTRODUCTION
Theory of Mind (ToM), regarded as an essential prerequisite for successful human social
interaction (Adolphs, 2003), is the ability to infer and predict intentions, thoughts, desires and
behavioral reactions to oneself and others, through an awareness that others have a mind with
“affective” and “cognitive” mental states that may differ from one’s own (Frith and Frith, 1999).
Considering that social interaction, among the cognitive aspects that may impact adherence to
treatment and patients’ quality of life (QoL), has been increasingly shown to be impaired in
neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS; Elamin et al., 2012;
Santangelo et al., 2012; Yamada et al., 2015; Burke et al., 2016a), an early assessment of this
domain in the disease course could be useful for positively conditioning patients’ management
and prognosis. In particular, with regard to ALS, a multisystem neurodegenerative disease, not
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only characterized by motor dysfunctions, but also by extra-
motor symptoms, belonging to the clinical and pathological
spectrum of FTLD (Lillo et al., 2012; Ling et al., 2013; Trojsi
et al., 2015; Burrell et al., 2016), the growing evidence of social
cognition impairments may have important implications on
patient’s QoL and ability to engage competently in end-of-life
decisions (Chiò et al., 2004; Lulé et al., 2013; Körner et al., 2015).
From the anatomical point of view, the cognitive and affective
aspects of ToM have been demonstrated to be supported by
dissociable, yet interacting, prefrontal networks (Shamay-Tsoory
et al., 2004). Specifically, the “cognitive” ToM network primarily
engages the dorsomedial prefrontal cortex, the dorsal anterior
cingulate cortex and the dorsal striatum, while the “affective”
ToM network engages the ventromedial and orbitofrontal
cortices, the ventral anterior cingulate cortex, the amygdala
and the ventral striatum (Poletti et al., 2012). In this regard,
several lesion studies have provided evidence that ToM could be
considered a multidimensional construct (Shamay-Tsoory et al.,
2005, 2006; Gupta et al., 2012; Sebastian et al., 2012) and the
different ToM subcomponents have been explored in vivo by
several cognitive and affective ToM tasks, such as the false-beliefs
tasks (Wimmer and Perner, 1983; Baron-Cohen et al., 1985) and
the Reading the Mind in the Eyes or Eyes Task (ET; Baron-Cohen
et al., 1997, 2001), the former prototypical for the assessment of
cognitive ToM, the latter for the assessment of the affective ToM.
However, there is a body of literature criticizing how ToM is used
and investigated (Frith and Happé, 1994a; Bloom and German,
2000).
With regard to the investigation of “affetive” and “cognitive”
components of ToM in neurologic disorders, significant deficits
have been revealed in cortical (i.e., Alzheimer’s disease and
Frontotemporal Lobar Degeneration or FTLD; Poletti et al., 2012)
and frontal-subcortical (Snowden et al., 2003; Meier et al., 2010;
Crespi et al., 2014) neurodegenerative diseases. Impairment of
social cognition has also been described in several cohorts of
patients in heterogeneous stages of ALS (Girardi et al., 2011;
Van der Hulst et al., 2015; Burke et al., 2016a,b). Moreover,
abnormalities of both cognitive and affective ToM, related to
social behavior dysfunctions, such as loss of empathy and
apathy (Gregory et al., 2002; Girardi et al., 2011), have been
recently confirmed as a prominent feature of behavioral profile
in advanced ALS (Van der Hulst et al., 2015). Approximately 5–
15% of ALS patients meet the diagnostic criteria for FTLD (Neary
et al., 1998; Rascovsky et al., 2011), predominantly developing
clinical features typical of the behavioral variant frontotemporal
dementia (bvFTD; Lomen-Hoerth, 2004) and a larger proportion
of non-demented ALS patients shows cognitive (mainly involving
the executive domain) and/or behavioral deficits, belonging to
a spectrum of symptoms frequently recognized within FTLD
syndromes (Lomen-Hoerth, 2004; Abrahams et al., 2005; Burrell
et al., 2016). With regard to social cognitive deficit in ALS, as
well as in overall the disease spectrum of FTLD (Elamin et al.,
2012), Burke et al. (2016b) demonstrated that ET is a valid
measure of the cognitive decline in this domain in ALS patients,
also in terms of severity, showing, in a previous study (Burke
et al., 2016a), that patients with ALS with bulbar onset (ALS-B)
may perform worse in this task, thus supporting the view that
ALS-B may represent a biologically more aggressive phenotype
of the disease (Cardenas-Blanco et al., 2014). Moreover, Van der
Hulst et al. (2015) revealed that in advanced ALS impairment of
both subcomponents of ToM may be associated with apathy and
impairment of frontotemporal-related abilities, such as verbal
fluency and naming abilities, suggesting that evidence of both
deficits may reflect a widespread degeneration of frontal lobes as
the disease progresses.
To note, there are opposing views in the literature with regard
to the relationship between ToM performances and executive or
behavioral skills (Baron-Cohen et al., 1985; Bertoux et al., 2016)
and, with regard to ALS, some studies, which were performed
in small and phenotypically heterogeneous samples of patients,
showed that ToM deficits were not selectively associated with
executive dysfunctions (Meier et al., 2010; Cavallo et al., 2011;
Girardi et al., 2011). On the contrary, Carluer et al. (2015)
revealed a significant association between alterations of the
cognitive subcomponent of ToM and executive functions in the
early stages of the disease.
On this background, given that the potential existence of ToM
abnormalities in the early stages of ALS and in different ALS
onsets are not still completely elucidated, in the present study,
we aimed to investigate whether cognitive and affective ToM are
impaired in a small sample of well-characterized ALS patients,
who were in King’s stages 1 and 2 of the disease (Balendra et al.,
2015) and were stratified for disease onset. We classified the
patients according to the King’s staging system, that account for
having reached different milestones of the disease related to the
number of regions involved (Balendra et al., 2015), differently
from Milano-Torino Staging system (MITOS; Chiò et al., 2015),
that captures the observed progressive loss of independence and
function. Moreover, considering that correlations between ToM
performances and neurobehavioral and QoL aspects, although
remarkable for ALS patients’ management, are still largely
debated, we also explored neuropsychological and behavioral
correlates of cognitive and affective ToM performances in our
population, assessing potential impairment of executive, memory
[i.e., the two cognitive domains reported to be impaired in ALS
(Phukan et al., 2012; Montuschi et al., 2015)] and behavioral
domains, arising from alteration of frontal and subcortical
regions (Tsermentseli et al., 2012), and the impact of ToM
dysfunctions on patients’ QoL.
MATERIALS AND METHODS
Patients
In the present study, 22 right-handed and native Italian speakers
patients, with probable and probable laboratory- supported ALS,
according to the El-Escorial revised criteria (Brooks et al., 2000),
were consecutively recruited at the First Division of Neurology of
the Università degli Studi della Campania “L. Vanvitelli” (Naples,
Italy). To be included in this study, which aimed to evaluate
ToM performance in ALS patients without the confounding
effect of other cognitive abnormalities, patients had to satisfy the
following inclusion criteria: (a) to have an age- and education-
adjusted score >71.78 on Addenbroke’s Cognitive Examination
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Revised (ACE-R) [according to the Italian validated version of
ACE-R (Siciliano et al., 2016)], a tool used to screen participants
in terms of overall cognitive ability; (b) to exhibit preserved verbal
comprehension abilities, needed to correctly execute the ToM
tasks adopted in this study, assessed by Token Test, according
to previous evidence (Hermann et al., 1992; Santangelo et al.,
2012; Maseda et al., 2014) [age- and education-adjusted score
>26.25 (Spinnler and Tognoni, 1987)]; (c) to be in stages 1
and 2 of ALS according to the King’s clinical staging system,
based on the appearance of sequential clinical milestones during
the ALS course, without including cognitive information (i.e.,
stage 1 = impairment of one body site; stage 2 = impairment
of two body sites; stage 3 = impairment of three body sites;
stage 4 = non-invasive ventilation or percutaneous endoscopic
gastrostomy; Balendra et al., 2015); (d) to use no medication
influencing cognitive performances. Clinical parameters were
measured in all ALS patients using the ALSFRS-R score, an
ALS-specific measure of functional ability (Cedarbaum et al.,
1999), and the upper motor neuron (UMN) score, a measure of
pyramidal dysfunction through the evaluation of the number of
pathological reflexes elicited from 15 body sites (Turner et al.,
2004).
None of patients carried C9ORF72, SOD1, TARDBP, and
FUS/TLS genes mutation.
Fifteen healthy control subjects (HCs), enrolled by “word
of mouth,” were age-, sex-, and education-matched with ALS
patients for adequately selecting the control group. Given that
HCs underwent the same neuropsychological assessment of ALS
patients, the recruited HCs were cognitively normal and those
with comorbid neurological, psychiatric, or medical conditions
that could affect cognition were excluded.
The research was conducted according to the principles
expressed in the Declaration of Helsinki. Ethics approval was
obtained from the Ethics Committee of the Università degli studi
della Campania “L. Vanvitelli”. Written informed consent was
obtained from each participant.
Neuropsychological Assessment
A 60-min neuropsychological battery, assessing cognitive
functioning/ability (global cognitive assessment and executive,
memory and abstract reasoning abilities), ToM abilities, frontal
behavioral disorders, and QoL, was designed by a team of
neurologists and neuropsychologists experienced in the study
and management of motor neuron diseases and cognitive
decline. Although this neuropsychological battery was not ALS-
specific, the tests administered have been widely used in ALS
and other movement disorders (Phukan et al., 2012; Santangelo
et al., 2012; Montuschi et al., 2015; Burke et al., 2016a), since
they were less influenced by motor symptoms. All tests were
administered in the morning following the same sequence for
avoiding possible interference of the answers of one test over the
others (Montuschi et al., 2015). In particular, after 1 day from
assessment of global cognitive functions and, then, executive,
memory, visuospatial, behavioral, and mood functions, patients
underwent ToM assessment. Moreover, if the subject was too
tired during testing, a further session was scheduled to complete
the battery within 2 weeks after the first one. Considering that
respiratory dysfunction may impact cognitive performances
(Kim et al., 2007; Gülhan et al., 2015; Braley et al., 2016), oxygen
saturation, and forced vital capacity (FVC) were measured at the
time of each examination (i.e., none participant showed oxygen
saturation <92 mmHg and FVC < 80%; Montuschi et al., 2015).
Given the aim of exploring neuropsychological and behavioral
correlates of cognitive and affective ToM performances in our
population, the neuropsychological protocol adopted allowed to
assess: (1) executive performances (i.e., mainly the inhibitory
control as specific executive function) by Stroop Color-Word
Interference test using the Stroop Executive Factor (SEF; Caffarra
et al., 2002), that accounts for motor disability (Phukan et al.,
2012; Burke et al., 2016a); (2) long-term verbal memory
by memory prose test (Novelli et al., 1986); (3) non-verbal
abstract reasoning and current intellectual functioning by Raven’s
Colored Progressive Matrices (RCPM; Carlesimo et al., 1996);
and (4) behavioral dysfunctions and mood by Frontal Systems
Behaviour (FrSBe) Scale (Grace et al., 1999), referring to the total
scores at the time of examination, derived from the caregivers’
forms, proven to be not influenced from motor symptoms
(Terada et al., 2011; Chiò et al., 2012) and Beck Depression
Inventory-II (BDI-II; Innamorati et al., 2013). Caregiver burden
was assessed by means of Caregiver Burden Inventory (CBI), a
self-administered questionnaire evaluating the effect of caring
on the caregiver (Novak and Guest, 1989). It comprised 24-
item and its scores ranged from 0 (lowest level) to 100 (highest
level). Finally, the ALS patients completed the Italian version
of the Short Form-36 (SF-36; Apolone and Mosconi, 1998), in
order to evaluate eight domains of QoL (i.e., physical functioning,
limitations in everyday activities, bodily pain, general health,
vitality, social functioning, emotional problems, and mental
health). For each domain an aggregate percentage score was
produced, which ranged from 0% (lowest or worst possible
level of functioning) to 100% (highest or best possible level of
functioning). In the present study, we considered the Italian
standards to calculate z-score for each domain of SF-36 (Apolone
and Mosconi, 1998).
After this preliminary evaluation, to explore ToM
abnormalities in the early stages of ALS and in different ALS
onsets, the participants underwent three ToM tasks that covered
both cognitive and affective subcomponents. In particular, the
advanced test of ToM (ATT), mainly considered a cognitive
task, has been designed to investigate the ability to attribute
mental states to others (Happé, 1994; Prior et al., 2003). The
task included 13 written stories describing naturalistic situations
in which two or more characters interacted with each other
as in familiar or social contexts (e.g., children arguing about
a toy’s property, a mother chiding a son for not appreciating
food, children pretending to behave as adults). The examiner
had to read each story and, then, asked the participants why
the characters behaved as they did. The total score ranged from
0 (worst performance) to 13 (best performance). Successful
performance requires attribution of mental states such as desires,
beliefs or intentions, and also higher orders mental states such
as one character’s belief about what another character knows.
The emotion attribution task (EAT; Prior et al., 2003), used
to assess the ability to attribute emotional states to others,
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included 35 written stories describing emotional situations
(e.g., an employee apprehending to receive an extra salary, a
man attacked by a big black spider, a woman finding a worm
in her food): the examiner had to read each story and, then,
asked the participants what the main protagonists might feel
in that situation. Five stories were designed to elicit attribution
of sadness, fear, embarrassment, disgust, happiness, anger, or
envy (five stories for each emotion). The total score ranges
from 0 (worst performance) to 35 (best performance). Finally,
we also administered the ET, consisting of the presentation of
photographs of the eye regions of human faces to participants
who were required to choose which word best describes what the
individual in the photograph is thinking or feeling (Baron-Cohen
et al., 2001). A control task, designed to investigate participants’
ability to correctly identify human physical attributes, such as
gender, was undertaken subsequently. Participants provided
verbal responses and could take as long as they wanted to
respond. All participants were encouraged to consult a glossary
of all mental state terms for a correct interpretation of the lexicon
in any case where they were unsure of a word (Baron-Cohen
et al., 2001). To note, with regard to HCs, the ATT and ET scores
were similar to those revealed in other samples of normal adults
(Baron-Cohen et al., 2001; Santangelo et al., 2012, 2013; Sato
et al., 2016).
Statistical Analysis
With regard to continuous variables, a multivariate analysis
of variance (MANOVA), followed by multivariate analysis of
covariance (MANCOVA), where appropriate, were performed
for between-group comparisons. To reduce the risk of type I error
associated with multiple comparisons, Bonferroni adjustments
were made, with p set at α/n (where n = number of variables
considered: 0.05/8= 0.006).
To compare ALS patients’ performance on cognitive and
affective ToM tasks, standardized z scores were calculated
with reference to control group’s means and SD. The z
scores displayed the relative degree of impairment from
normal performance in SD units, thereby allowing to compare
scores on ET, ATT and EAT within ALS group by a
one-way ANOVA for repeated measures. We checked the
data for normality using several procedures (i.e., Shapiro–
Wilk normality test, kurtosis and skewness). Within the ALS
group, Pearson’s correlation analysis, followed by Bonferroni
correction (0.05/5 = 0.01 for demographic and clinical
variables; 0.05/5 = 0.01 for neuropsychological variables;
0.05/14 = 0.003 for neurobehavioral variables) was carried out
to explore potential associations between ToM performances and
demographic (age and education), clinical (disease duration, and
disease severity assessed by ALSFRS-R and UMN), cognitive,
behavioral, and QoL features.
RESULTS
Demographic Variables
Twenty-two (9 females and 13 males) ALS patients (i.e., 9
with bulbar-onset and 13 with spinal-onset ALS) and 15 HCs
(7 females and 8 males), age- and education-matched, were
included in the present study. With regard to characterization
of clinical phenotypes of ALS (Chiò et al., 2011), patients
exhibited “classic” (Charcot’s; i.e., onset of symptoms in the
upper/lower limbs, with clear but not predominant pyramidal
signs) and “bulbar” (i.e., bulbar onset without peripheral spinal
involvement for the first 6 months after symptoms onset)
phenotypes. Moreover, according to the King’s clinical staging
system (Balendra et al., 2015), based on the identification
of sequential “clinical milestones” during the ALS course,
10 patients were in stage 1 and 12 in stage 2. For more
details about demographic and clinical characteristics, see
Table 1.
Neuropsychological Assessment:
Between-Group Comparisons
With regard to neuropsychological and neurobehavioral
variables, MANOVA with Bonferroni post hoc test showed
significant difference between ALS patients and HCs on memory
prose test (p < 0.006; Table 2). Therefore, MANCOVA analysis,
with memory prose test as covariate, showed that ALS patients
performed significant lower scores than HCs on EAT and ET, but
not on ATT task (Table 3). The values of η2 (Table 3) for each
ToM variable were>0.14, indicating a large effect (Cohen, 1988).
With regard to the within-group comparisons, no significant
differences were revealed by comparing EAT, ATT, and ET scores
in the ALS group (i.e., one-way ANOVA for repeated measures:
F = 1.217, p= 0.301).
With regard to phenotypic characterization, statistical analysis
showed that patients with bulbar-onset had lower scores than
patients with spinal-onset on ET, while no significant differences
between the two groups were found on ATT and EAT (Table 4).
Moreover, within both bulbar- and spinal-onset groups, EAT,
ATT, and ET scores were not significantly different (by one-
way ANOVA for repeated measures: in bulbar-onset group,
F = 0.605, p = 0.485; in spinal-group onset, F = 2.022,
p= 0.156).
TABLE 1 | Demographic, clinical, and neuropsychological features of ALS
patients and healthy control subjects (HCs; mean ± SD).
Demographic and
clinical parameters
ALS patients
(n = 22)
HCs
(n = 15)
F/χ2 p
Age 58.19 ± 9.63 55.4± 8.72 1.586 0.218
Education (years) 11.38 ± 4.55 9.93± 2.68 2.584 0.119
Gender (M:F) 13:9 8:7 0.120 0.729
Disease duration∗ 18.73 ± 10.87 –
ALSFRS-R total score 41 ± 3.86 –
ALSFRS-R bulbar subscore 10.45 ± 1.68 –
ALSFRS-R arm subscore 9.54 ± 2.1 –
ALSFRS-R leg subscore 9.18 ± 2.46 –
ALSFRS-R respiratory
subscore
11.7 ± 0.7 –
UMN score 6.50 ± 4.68 –
∗Months from symptom onset to assessment. ALSFRS-R, amyotrophic lateral
sclerosis functional rating scale; UMN, upper motor neuron.
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TABLE 2 | Neuropsychological features of ALS patients and HCs (mean ± SD).
Neuropsychological parameters [raw scores] ALS patients (n = 22) HCs (n = 15) F p
ACE-R 87.71 ± 8.96 93.07 ± 3.24 4.522 0.042
Token test 33.72 ± 2.02 34.93 ± 1.38 3.429 0.075
Memory prose test 11.53 ± 2.83 15.13 ± 1.60 14.476 0.001
RCPM 26.15 ± 5.19 29.80 ± 4.52 5.554 0.026
Stroop executive factor 0.30 ± 0.733 0.20 ± 0.561 0.600 0.445
BDI 12.37 ± 6.57 10.40 ± 8.24 0.640 0.430
CBI 19.28 ± 15.74 –
SF-36: physical functioning (z score) 43.33 ± 27.23 (−1.7) –
SF-36: role-physical (z score) 28.33 ± 39.94 (−1.3) –
SF-36: bodily pain (z score) 57.73 ± 24.98 (−0.5) –
SF-36: general health (z score) 43.13 ± 17.18 (−0.9) –
SF-36: vitality (z score) 54 ± 20.80 (−0.3) –
SF-36: social functioning (z score) 60.60 ± 23.06 (−0.7) –
SF-36: role-emotional (z score) 50.87 ± 39.53 (−0.6) –
SF-36: mental health (z score) 62.40 ± 20.2 (−0.2) –
FrSBe [caregiver forms, total score] 79.33 ± 12.12 –
FrSBe [caregiver forms, apathy subscore] 25.77 ± 5.5 –
FrSBe [caregiver forms, disinhibition subscore] 22.05 ± 3.81 –
FrSBe [caregiver forms, executive dysfunction subscore] 31.5 ± 6.1 –
ACE-R, Addenbrooke’s cognitive examination; CBI, caregiver burden inventory; BDI, beck depression inventory; FrSBe, frontal systems behaviour; RCPM, Raven’s colored
progressive matrices; SF-36, short form-36. The z score for each domain of SF-36 was calculated using mean and SD of Italian normative sample (Apolone and Mosconi,
1998). The statistically significant results after Bonferroni correction [p < 0.006] are reported in bold.
Correlation Analysis
Within the ALS sample, EAT and ET scores were significantly
correlated with each other (r = 0.586, p = 0.011), while ATT
did not correlate with other ToM scores. EAT scores were
significantly correlated with education (r = 0.587, p = 0.006),
ACE-R (r = 0.593, p = 0.008), memory prose (r = 0.659,
p = 0.003), RCPM (r = 0.655, p = 0.003), and SF-36 “Mental
Health” (r = 0.570, p = 0.033; uncorrected level of significance)
scores, while ET scores were correlated with ACE-R (r = 0.581,
p = 0.014; uncorrected level of significance), memory prose
(r = 0.546, p = 0.029; uncorrected level of significance) and
RCPM (r = 0.510, p = 0.044; uncorrected level of significance)
scores. Finally, EAT, ET, and ATT scores were not correlated with
other executive and non-executive neuropsychological variables
and behavioral measures were not associated with any ToM
scores.
DISCUSSION
The present cross-sectional study revealed an early impairment
of ToM abilities in ALS patients, especially in those with bulbar
onset, thus suggesting that non-demented ALS patients may have
difficulties in attributing emotions and mental states to others.
Moreover, from early stages of ALS, this neuropsychological
profile may be significantly related to altered memory prose and
non-verbal abstract reasoning. Another evidence derives from
the association between impaired performances on EAT and its
impact on health-related QoL of ALS patients, considering the
potential consequences of deficits of social conduct, linked to
ToM alterations, on QoL.
Abnormalities of the attribution of emotional and social
intentions, found in several cohorts of ALS patients (Cavallo
et al., 2011; Girardi et al., 2011), resemble the affective profile
that characterizes FTLD patients, especially in mild and moderate
stages of bvFTD (Torralva et al., 2015), corroborating the theory
of a clinicopathological continuum between ALS and FTLD
(Lillo et al., 2012; Ling et al., 2013; Trojsi et al., 2015). In
particular, patients with bvFTD are characterized, from the early
stages of disease, by significant changes in personality and social
conduct (Piguet et al., 2011), mainly related to early alterations
of ventromedial prefrontal areas (Lillo et al., 2012), where a
similar pattern of prefrontal structural (Lillo et al., 2012; Crespi
et al., 2014) and functional (Trojsi et al., 2015) abnormalities
may also be revealed in ALS patients, although in later stages
of the disease. Our findings remark that an impairment of both
subcomponents of ToM, especially of the affective one, explored
by both EAT and ET, might be considered as an extra-motor
symptom occurring since the early stages of ALS, allowing to
speculate that these poor performances may reflect mainly an
TABLE 3 | Performance of ALS patients and control subjects on tasks
assessing ToM abilities (mean ± SD).
Parameters ALS patients Controls F P η2
(n = 22) (n = 15)
EAT 24.95 ± 3.72 27.47 ± 3.46 8.606 0.001 0.381
ATT 8.14 ± 2.57 8.67 ± 1.40 1.514 0.237 0.098
ET 20.67 ± 6.02 22.93 ± 5.12 6.878 0.004 0.329
ATT, advanced test of ToM; EAT, emotion attribution task; ET, eyes test; ToM, theory
of mind.
The statistically significant results are reported in bold.
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TABLE 4 | Neuropsychological performances (mean ± SD) of ALS patients
with bulbar-onset compared to those of patients with spinal-onset.
Neuropsychological
parameters (raw
scores)
Bulbar-onset
ALS
Spinal-onset
ALS
F p
ACE-R 87 ± 9.84 89.45 ± 8.07 0.045 0.834
Token test 33.20 ± 2.16 34.32 ± 1.87 0.725 0.406
Memory prose test 11.50 ± 3 12.36 ± 2.22 0.689 0.417
RCPM 25.40 ± 6.10 27 ± 5.27 0.641 0.434
Stroop executive factor 0.20 ± 0.477 0.36± 0.924 0.059 0.811
EAT 24 ± 4.69 25.82 ± 3.28 0.643 0.433
ATT 7.80 ± 2.77 8.82 ± 2.08 0.812 0.379
ET 16 ± 5.74 23 ± 5.58 0.438 0.033
ACE-R, Addenbrooke’s cognitive examination; ATT, advanced test of theory of
mind; CBI, caregiver burden inventory; EAT, emotion attribution task; ET, eyes
test; FrSBe, frontal systems behavior scale; RCPM, Raven’s colored progressive
matrices; SF-36, short form-36.
The statistically significant results are reported in bold.
early medial and orbital prefrontal cortex dysfunction, as also
shown in early clinical stages of frontal lobe degeneration in
both ALS (Van der Hulst et al., 2015) and bvFTD (Torralva
et al., 2015). However, despite the large amount of literature
investigating the behavioral and neural bases of mentalizing
abilities in neurological conditions, there is still a lack of validated
neuropsychological tools specifically designed to assess each ToM
subcomponent (Dodich et al., 2015; Schaafsma et al., 2015). To
note, among the experimental approaches used in neurological
disorders, not all investigations on ALS aimed to assess both
cognitive and affective subcomponents of ToM (Girardi et al.,
2011; Carluer et al., 2015) and some authors explored mainly the
affective subcomponent using non-verbal tasks, based on visual
emotion recognition (such as ET or preference judgment task or
false-belief task; Cavallo et al., 2011; Girardi et al., 2011; Crespi
et al., 2014; Carluer et al., 2015; Van der Hulst et al., 2015; Burke
et al., 2016a).
The distinction between affective and cognitive
subcomponents of ToM has been essentially demonstrated
by using different ToM tests with respect to their cognitive
(e.g., belief about belief) or affective (e.g., belief about feelings)
request. In this regard, a sound tool to investigate both ToM
subcomponents using a verbal task is the “faux pas recognition”
(FPR) test in which the participants hear 10 stories read aloud,
containing a social faux pas and 10 control stories. After each
story, participants are asked whether anyone said anything
that they should not have said (i.e., evaluation of the affective
subcomponent) and, when a faux pas is detected, further
clarifying questions are proposed in order to evaluate the
understanding of the mental states of the agents involved in
the stories (i.e., evaluation of the cognitive component). In our
study a strength point of the experimental design was to have
investigated both subcomponents using verbal and non-verbal
tasks in order to adequately assess the multifaceted aspects of
the ToM abilities. However, there are some intrinsic limitations
of the ToM tasks that, we adopted. In fact, there are no specific
considerations concerning the role of ATT in the affective
rather than in the cognitive ToM (Happé, 1994): AAT could
be considered mainly a cognitive task, although it seems to
be less associated to executive functions and less sensitive to
neurological disorders (Aboulafia-Brakha et al., 2011). Moreover,
it is to take into account that personality traits, especially with
regard to antisocial component and self-presentation (i.e., the
tendency to report social desirability), may impact Happé’s test
of ToM also in non-psychopathic subjects (Nentjes et al., 2015),
probably influencing ToM performances also in HCs subjects.
With regard to ET, considered the prototypical test to explore
the affective subcomponent, it has been proven that cognitive
ToM and executive abilities may impact the performance on this
test (Bull et al., 2008; Dal Monte et al., 2014) that, therefore,
should not be considered as a purely affective task.
On this background, our correlation analysis between the
ToM scores and those derived from memory prose and RCPM
tests showed that these neuropsychological measures were related
to both EAT and ET, although only correlations with EAT
were significant after Bonferroni correction. Together, these
results support the hypothesis that mechanisms involving not
only executively demanding abilities may be linked to early
defects of ToM in ALS. To note, with regard to the debated
association existing between executive and ToM domains,
Bertoux et al. (2016), by applying a “clustering” approach to
a large neuropsychological database derived from a population
of bvFTD patients, revealed that executive functions “clustered”
separately from ToM measures, substantially demonstrating that
they were distinct components. Interestingly, Bertoux et al.
(2016) found different relationships with executive functions
across ToM subcomponents, showing that only the intention
and empathy components, as measured by the FPR test, were
linked to attention/working memory and verbal abstraction
performances. Moreover, the lack of significant association
between executive performances (especially the inhibitory
control) and ToM performances may be explained considering
that the advanced ToM tasks adopted have been proven to be
more associated to language and memory functions in other
neurological disorders (Castelli et al., 2011; Freed et al., 2015;
Robinson et al., 2016), as also shown in our study with regard to
the association between EAT and memory prose performances.
Our observation of a significant association between
dysfunctions of less executively demanding conditions (i.e.,
memory and RCPM performances) and impairment of ToM
in early ALS may suggest a potential independence between
executive abilities and ToM performances. Some evidence
supports a stronger association between executive functions
and “fluid intelligence,” both involving mainly dorsolateral
prefrontal networks (Roca et al., 2012), in contrast to ToM
processes, hypothesized to be probably more dependent from
medial prefrontal networks, especially with regard to the affective
subcomponent (Shamay-Tsoory et al., 2005, 2006; Xi et al.,
2011; Bertoux et al., 2016). However, more recently, Burke
et al. (2016b) demonstrated a significant impairment of ET, as
a measure of affective social cognition, in ALS patients with
executive dysfunctions compared to healthy subjects. Probably,
these inconsistent results may be due by the fact that the
anatomical and biological bases of the ToM performances are
still debated. In this regard, it has been suggested that ToM is
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a complex function involving multiple subprocesses and, thus,
the evidence for a ToM network may be considered limited
and contentious (Poletti et al., 2012; Schaafsma et al., 2015).
Moreover, there is an increasing propensity to abandon the
notion that ToM is a single cognitive ability grounded in a single
set of brain regions, in favor of the potential existence of a reliably
activated functional brain network (Schaafsma et al., 2015).
To note, the patients examined in the present study did not
show cognitive or behavioral impairment that would negatively
impact their performance in the ToM tasks proposed, except
for the performance on the memory prose test. This finding
corroborated previous evidence that also memory functions,
although to a milder degree than executive abilities, may be
affected in the ALS course (Machts et al., 2014; Raaphorst
et al., 2015; Beeldman et al., 2016). In particular, the anatomical
hallmarks of memory dysfunction in ALS have been recently
identified in a progressive disease-related decline of hippocampal
volume (Abdulla et al., 2014; Raaphorst et al., 2015). Moreover,
although memory impairment may characterize cognitive profile
of ALS patients with C9ORF72 mutation (Patel and Sampson,
2015), no patient studied in our work exhibited the C9ORF72
gene expansion.
Previous neuropsychological evidence, derived from cross-
sectional (Abrahams et al., 1997; Montuschi et al., 2015) and
longitudinal (Abrahams et al., 2005; Schreiber et al., 2005; Elamin
et al., 2012) studies, identified a prominent decline of executive
and language performances in ALS patients, more strikingly in
bulbar (Montuschi et al., 2015) and pseudobulbar (Abrahams
et al., 1997) phenotypes. In particular, some longitudinal studies
identified cognitive decline early in the disease course, showing a
prominent impairment of cognitive domains attributed to frontal
and temporal lobes (Abrahams et al., 2005; Schreiber et al., 2005;
Elamin et al., 2012). With regard to deterioration of cognitive
functions across the ALS course, Schreiber et al. (2005) showed
that cognitive deficits did not progress in synchrony with motor
decline, but more slowly, although patients with bulbar-onset
ALS had a relatively greater cognitive impairment over time
than subjects with spinal-onset. More recently, Elamin et al.
(2012) showed that detection of executive dysfunctions at ALS
onset might be associated with significantly faster motor decline,
particularly in the bulbar sites. In line with this evidence, the
results of our analysis, reporting significantly lower ET scores
in patients with bulbar-onset compared to those with spinal-
onset, more clearly suggest that ALS patients with bulbar-onset
may be also more prone to impairment of social-affective abilities
than those with spinal-onset, reflecting recent findings by Burke
et al. (2016a), who revealed that bulbar-onset patients performed
worse than spinal-onset ones on ET. Longitudinal studies looking
at changes in ToM performance over time in case of both disease
onsets should be performed to investigate if difference between
bulbar and spinal onset patients persists or even increases as the
disease progresses.
We also revealed that EAT scores were correlated with
education and “Mental Health” measures of SF-36. The former
correlation may suggest a potential role of years of education as
a moderator factor of ToM abilities, especially for the affective
subcomponent, as also demonstrated in studies performed in
healthy populations that examined ET performances in relation
to some demographic variables, including years of education
(Fernández-Abascal et al., 2013; Ayesa-Arriola et al., 2016). In
this regard, our results, although deserving further investigation
because only correlational and not causal, may support the notion
that education could influence and improve social cognition,
thus encouraging the use of training programs, as demonstrated
in other neuropsychiatric conditions (Rocha and Queirós, 2013;
Sacks et al., 2013). Moreover, at the clinical level, the growing
evidence of social cognition impairment in ALS may have
crucial implications for patients’ and caregivers’ training during
the whole course of the disease. However, the faster trajectory
of ALS progression compared to the disease course of other
neurological disorders could significantly impact the clinical
efficacy and application of these approaches, thus requiring an
earlier intervention for effectively impacting on social cognition.
On the other hand, the crucial role of interventions aimed at
reducing psychological distress in caregivers of ALS patients is in
line with more recent results from our research group, performed
on a larger population of patients and caregivers, which
revealed significant correlations between intensity of burden and
caregivers’ coping strategies (unpublished data). Furthermore,
the lack of correlation shown in the present work between
caregiver burden and patients’ ToM scores, together with
previous evidence that revealed significant associations between
higher burden in carers and higher behavioral dysfunctions in
patients with ALS (Chiò et al., 2010; Burke et al., 2015) and
bvFTD (Brioschi Guevara et al., 2015), underlined the fact that
mainly apathy and disinhibition, but also loss of empathy, more
specifically explored by a more detailed behavioral assessment
(Van der Hulst et al., 2015), may negatively impact caregiver
burden.
In addition, the latter significant correlation observed between
EAT scores and “Mental Health” dimension of SF-36 suggests
that the impairment of ToM may negatively affect mainly this
aspect of patients’ QoL. In agreement with this association,
although demonstrated by our analysis as only “correlational”
and not causal, QoL may be considered mainly dependent on
psychological and existential factors in ALS (Simmons et al.,
2000), thus inducing to emphasize the role of spiritual aspects and
support systems in therapeutic interventions. However, “Mental
Health” and “Role Emotional” domains of SF-36 have been
demonstrated less impaired during the ALS course in comparison
to “Physical Functioning” and “Role Physical” domains (De
Groot et al., 2007), thereby depicting diverging patterns between
“physical” and “mental health” domains of QoL in those patients.
Although the interesting insights discussed, our study has
some limitations, principally related to the characteristics of
the cohort studied (i.e., with regard to the size, the early
stage of disease and the cognitive profile), the monocentric
affiliation of the patients enrolled and the neuropsychological
assessment performed [i.e., we did not use ALS-specific tools,
such as the Edinburgh Cognitive and Behavioral ALS Screen
battery (Abrahams et al., 2014), not still validated in Italian
populations at the time of this study, and did not evaluate verbal
fluency indices for accounting for motor disability, but only SEF
(Phukan et al., 2012; Burke et al., 2016a)]. Moreover, especially
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in case of full battery assessment, the use of ALS-specific
psychometrics should be considered. To note, a significant
limitation of our analysis is the lack of working memory
assessment, although working memory may have a potential
confounding effect on the ToM tasks adopted. With regard to
the language domain, although verbal comprehension, screened
in our study by Token Test, was not impaired in both patients
and HCs, it is to take into account that social communication
disorders may be more specifically linked to alterations of ToM
performance. In particular, autism may provide a sound model
for studying the important distinction between language and
communication and, thus, the effects of communication deficit
on social cognition. In fact, in case of subjects with autism
spectrum disorders, who associate selective impairment of ToM
performance, communication deficit has been proven to lie in
the use of language to affect other minds and language has been
revealed important only in so far as it may be used to give
evidence of own and other people’s thoughts and intentions (Frith
and Happé, 1994b; Pelphrey et al., 2011).
CONCLUSION
Our preliminary findings, although would need to be generalized
in the context of larger samples using appropriate adjustment
for executive dysfunctions, show that the ToM subcomponents
are altered from the early stage of ALS and that this dysfunction
may be related to the “Mental Health” of patients. Therefore,
potential clinical implications derived from our study may
concern the crucial role of early psychological interventions
focused on deficit of both ToM subcomponents and aimed
at strengthening patients’ coping strategies, interaction with
caregivers and, thus, ability to engage competently therapeutic
and end-of-life decisions, consequently improving patients’ QoL.
Future research may stimulate the use in clinical practice of more
detailed assessment of ToM and behavioral deficits.
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